|
1
|
Xu B, Chotewutmontri S, Wolf S, Klos U,
Schmitz M, Dürst M and Schwarz E: Multiplex identification of human
papillomavirus 16 DNA integration sites in cervical carcinomas.
PLoS One. 8:e666932013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Duvlis S, Popovska-Jankovic K, Arsova ZS,
Memeti S, Popeska Z and Plaseska-Karanfilska D: HPV E6/E7 mRNA
versus HPV DNA biomarker in cervical cancer screening of a group of
Macedonian women. J Med Virol. 87:1578–1586. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kares S, Veijalainen O, Kholova I,
Tirkkonen M, Vuento R, Huhtala H, Tuimala V, Mäenpää J and Kujala
P: HIGH-RISK HPV testing as the primary screening method in an
organized regional screening program for cervical cancer: The value
of HPV16 and HPV18 genotyping? APMIS. 127:710–716. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fani M, Mahmoodi P, Emadzadeh M, Avan A,
Karimi E, Ferns GA, Rezayi M and Amiri IS: Correlation of human
papil-lomavirus 16 and 18 with cervical cancer and their diagnosis
methods in Iranian women: A systematic review and meta-analysis.
Curr Probl Cancer. 44:1004932020. View Article : Google Scholar
|
|
5
|
DiGiuseppe S, Bienkowska-Haba M and Sapp
M: Human papillomavirus entry: Hiding in a bubble. J Virol.
90:8032–8035. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Taghizadeh E, Jahangiri S, Rostami D,
Taheri F, Renani PG, Taghizadeh H and Gheibi Hayat SM: Roles of E6
and E7 human papillomavirus proteins in molecular pathogenesis of
cervical cancer. Curr Protein Pept Sci. 20:926–934. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang HY, Park S, Lee D, Kim S, Kim G, Park
KH and Lee H: Prevalence of type-specific oncogenic human
papillomavirus infection assessed by HPV E6/E7 mRNA among women
with high-grade cervical lesions. Int J Infect Dis. 37:135–142.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang JJ, Cao XC, Zheng XY, Wang HY and Li
YW: Feasibility study of a human papillomavirus E6 and E7
oncoprotein test for the diagnosis of cervical precancer and
cancer. J Int Med Res. 46:1033–1042. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huibregtse JM, Scheffner M and Howley PM:
Localization of the E6-AP regions that direct human papillomavirus
E6 binding, association with p53, and ubiquitination of associated
proteins. Mol Cell Biol. 13:4918–4927. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Scheffner M, Werness BA, Huibregtse JM,
Levine AJ and Howley PM: The E6 oncoprotein encoded by human
papilloma-virus types 16 and 18 promotes the degradation of p53.
Cell. 63:1129–1136. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Martinez-Zapien D, Ruiz FX, Poirson J,
Mitschler A, Ramirez J, Forster A, Cousido-Siah A, Masson M, Vande
Pol S, Podjarny A, et al: Structure of the E6/E6AP/p53 complex
required for HPV-mediated degradation of p53. Nature. 529:541–545.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Crook T, Fisher C, Masterson PJ and
Vousden KH: Modulation of transcriptional regulatory properties of
p53 by HPV E6. Oncogene. 9:1225–1230. 1994.PubMed/NCBI
|
|
13
|
Mietz JA, Unger T, Huibregtse JM and
Howley PM: The transcriptional transactivation function of
wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6
oncoprotein. EMBO J. 11:5013–5020. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Malanchi I, Accardi R, Diehl F, Smet A,
Androphy E, Hoheisel J and Tommasino M: Human papillomavirus type
16 E6 promotes retinoblastoma protein phosphorylation and cell
cycle progression. J Virol. 78:13769–13778. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fischer M, Uxa S, Stanko C, Magin TM and
Engeland K: Human papilloma virus E7 oncoprotein abrogates the
p53-p21-DREAM pathway. Sci Rep. 7:26032017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Slebos RJ, Lee MH, Plunkett BS, Kessis TD,
Williams BO, Jacks T, Hedrick L, Kastan MB and Cho KR:
P53-dependent G1 arrest involves pRB-related proteins and is
disrupted by the human papillomavirus 16 E7 oncoprotein. Proc Natl
Acad Sci USA. 91:5320–5324. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Massimi P and Banks L: Repression of p53
transcriptional activity by the HPV E7 proteins. Virology.
227:255–259. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Almeida AM, Queiroz JA, Sousa F and Sousa
A: Cervical cancer and HPV infection: Ongoing therapeutic research
to counteract the action of E6 and E7 oncoproteins. Drug Discov
Today. 24:2044–2057. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiang Z, Chen K, Cheng L, Yan B, Qian W,
Cao J, Li J, Wu E, Ma Q and Yang W: Resveratrol and cancer
treatment: Updates. Ann NY Acad Sci. 1403:59–69. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zadi Heydarabad M, Vatanmakanian M,
Abdolalizadeh J, Mohammadi H, Azimi A, Mousavi Ardehaie R,
Movasaghpour A and Farshdousti Hagh M: Apoptotic effect of
resveratrol on human T-ALL cell line CCRF-CEM is unlikely exerted
through alteration of BAX and BCL2 promoter methylation. J Cell
Biochem. 119:10033–10040. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rasheduzzaman M, Jeong JK and Park SY:
Resveratrol sensitizes lung cancer cell to TRAIL by p53 independent
and suppression of Akt/NF-KB signaling. Life Sci. 208:208–220.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Casey SC, Amedei A, Aquilano K, Azmi AS,
Benencia F, Bhakta D, Bilsland AE, Boosani CS, Chen S, Ciriolo MR,
et al: Cancer prevention and therapy through the modulation of the
tumor microenvironment. Semin Cancer Biol. 35(Suppl 1): S199–S223.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hsu KF, Wu CL, Huang SC, Wu CM, Hsiao JR,
Yo YT, Chen YH, Shiau AL and Chou CY: Cathepsin L mediates
resveratrol-induced autophagy and apoptotic cell death in cervical
cancer cells. Autophagy. 5:451–460. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Garcia-Zepeda SP, Garcia-Villa E,
Diaz-Chavez J, Hernandez-Pando R and Gariglio P: Resveratrol
induces cell death in cervical cancer cells through apoptosis and
autophagy. Eur J Cancer Prev. 22:577–584. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim YS, Sull JW and Sung HJ: Suppressing
effect of resveratrol on the migration and invasion of human
metastatic lung and cervical cancer cells. Mol Biol Rep.
39:8709–8716. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao Y, Yuan X, Li X and Zhang Y:
Resveratrol significantly inhibits the occurrence and development
of cervical cancer by regulating phospholipid scramblase 1. J Cell
Biochem. Oct 22–2018.Epub ahead of print. View Article : Google Scholar : 2018.
|
|
27
|
Chatterjee K, Mukherjee S, Vanmanen J,
Banerjee P and Fata JE: Dietary polyphenols, resveratrol and
pterostilbene exhibit anti-tumor activity on an HPV E6-Positive
cervical cancer model: An in vitro and in vivo Analysis. Front
Oncol. 9:3522019. View Article : Google Scholar
|
|
28
|
Chatterjee K, AlSharif D, Mazza C, Syar P,
Al Sharif M and Fata JE: Resveratrol and pterostilbene exhibit
anticancer properties involving the downregulation of HPV
Oncoprotein E6 in cervical cancer cells. Nutrients. 10:2432018.
View Article : Google Scholar :
|
|
29
|
Mukherjee S, Debata PR, Hussaini R,
Chatterjee K, Baidoo JNE, Sampat S, Szerszen A, Navarra JP, Fata J,
Severinova E, et al: Unique synergistic formulation of curcumin,
epicatechin gallate and resveratrol, tricurin, suppresses HPV E6,
eliminates HPV+ cancer cells, and inhibits tumor
progression. Oncotarget. 8:60904–60916. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Popescu NC, DiPaolo JA and Amsbaugh SC:
Integration sites of human papillomavirus 18 DNA sequences on HeLa
cell chromosomes. Cytogenet Cell Genet. 44:58–62. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Choo CK, Rorke EA and Eckert RL:
Differentiation-independent constitutive expression of the human
papillomavirus type 16 E6 and E7 oncogenes in the CaSki cervical
tumour cell line. J Gen Virol. 75:1139–1147. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pattillo RA, Hussa RO, Story MT, Ruckert
AC, Shalaby MR and Mattingly RF: Tumor antigen and human chorionic
gonadotropin in CaSki cells: A new epidermoid cervical cancer cell
line. Science. 196:1456–1458. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Saha SK and Khuda-Bukhsh AR: Berberine
alters epigenetic modifications, disrupts microtubule network, and
modulates HPV-18 E6-E7 oncoproteins by targeting p53 in cervical
cancer cell HeLa: A mechanistic study including molecular docking.
Eur J Pharmacol. 744:132–146. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Souza RP, Bonfim-Mendonca PS, Gimenes F,
Ratti BA, Kaplum V, Bruschi ML, Nakamura CV, Silva SO, Maria-Engler
SS and Consolaro ME: Oxidative stress triggered by apigenin induces
apoptosis in a comprehensive panel of human cervical cancer-derived
cell lines. Oxid Med Cell Longev. 2017:15127452017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Meissner JD: Nucleotide sequences and
further characterization of human papillomavirus DNA present in the
CaSki, SiHa and HeLa cervical carcinoma cell lines. J Gen Virol.
80:1725–1733. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
37
|
Tornesello ML, Annunziata C, Tornesello
AL, Buonaguro L and Buonaguro FM: Human Oncoviruses and p53 tumor
suppressor pathway deregulation at the origin of human cancers.
Cancers (Basel). 10:2132018. View Article : Google Scholar
|
|
38
|
Filippova M, Evans W, Aragon R, Filippov
V, Williams VM, Hong L, Reeves ME and Duerksen-Hughes P: The small
splice variant of HPV16 E6, E6, reduces tumor formation in cervical
carcinoma xenografts. Virology. 450-451:153–164. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cerasuolo A, Buonaguro L, Buonaguro FM and
Tornesello ML: The role of RNA splicing factors in cancer:
Regulation of viral and human gene expression in human
papillomavirus-related cervical cancer. Front Cell Dev Biol.
8:4742020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ajiro M, Jia R, Zhang L, Liu X and Zheng
ZM: Intron definition and a branch site adenosine at nt 385 control
RNA splicing of HPV16 E6*I and E7 expression. PLoS One.
7:e464122012. View Article : Google Scholar
|
|
41
|
Evans W, Filippova M, Filippov V,
Bashkirova S, Zhang G, Reeves ME and Duerksen-Hughes P:
Overexpression of HPV16 E6* Alters β-Integrin and mitochondrial
dysfunction pathways in cervical cancer cells. Cancer Genomics
Proteomics. 13:259–273. 2016.PubMed/NCBI
|
|
42
|
Zhang P, Li H, Yang B, Yang F, Zhang LL,
Kong QY, Chen XY, Wu ML and Liu J: Biological significance and
therapeutic implication of resveratrol-inhibited Wnt, Notch and
STAT3 signaling in cervical cancer cells. Genes Cancer. 5:154–164.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Medina-Aguilar R, Marchat LA, Arechaga
Ocampo E, Gariglio P, García Mena J, Villegas Sepúlveda N, Martínez
Castillo M and López-Camarillo C: Resveratrol inhibits cell cycle
progression by targeting Aurora kinase A and Polo-like kinase 1 in
breast cancer cells. Oncol Rep. 35:3696–3704. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang TT, Schoene NW, Kim YS, Mizuno CS and
Rimando AM: Differential effects of resveratrol and its naturally
occurring methylether analogs on cell cycle and apoptosis in human
androgen-responsive LNCaP cancer cells. Mol Nutr Food Res.
54:335–344. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hsieh TC and Wu JM: Differential effects
on growth, cell cycle arrest, and induction of apoptosis by
resveratrol in human prostate cancer cell lines. Exp Cell Res.
249:109–115. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Fischer M and Muller GA: Cell cycle
transcription control: DREAM/MuvB and RB-E2F complexes. Crit Rev
Biochem Mol Biol. 52:638–662. 2017. View Article : Google Scholar : PubMed/NCBI
|
